Durata Therapeutics (DRTX) in Focus: Stock Up 5.64% - Tale of the Tape

Loading...
Loading...

Durata Therapeutics, Inc. DRTX was a big mover last session, as the company saw its shares jump nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This stock, trading in a volatile price range of $13.47 to $16.67 in the past one-month time frame, showed a pick-up yesterday at $14.23.

In the last 30 days, the company witnessed 1 upward estimate revision while 2 estimates were revised downward. Also, the Zacks Consensus Estimate of a loss has widened, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward to see if this high can last.

Durata Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is negative.

Some better-ranked stocks in the healthcare industry include Alexion Pharmaceuticals, Inc. ALXN, ANI Pharmaceuticals, Inc. ANIP and Aastrom Biosciences, Inc. ASTM all carrying a Zacks Rank #1 (Strong Buy).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>






ALEXION PHARMA ALXN: Free Stock Analysis Report

ANI PHARMACEUT ANIP: Free Stock Analysis Report

AASTROM BIOSCI ASTM: Get Free Report

DURATA THERAPT DRTX: Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research
Loading...
Loading...
Market News and Data brought to you by Benzinga APIs
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...